|
Name |
(1S,3S,4R,5S,8R,9S,10R,11R,14S,16R,18R)-5-benzyl-9,10-dihydroxy-3,12,14-trimethyl-2-methylidene-19-oxa-6-azapentacyclo[14.2.1.04,8.08,18.011,17]nonadec-12-en-7-one
|
Molecular Formula | C28H35NO4 | |
IUPAC Name* |
(1S,3S,4R,5S,8R,9S,10R,11R,14S,16R,18R)-5-benzyl-9,10-dihydroxy-3,12,14-trimethyl-2-methylidene-19-oxa-6-azapentacyclo[14.2.1.04,8.08,18.011,17]nonadec-12-en-7-one
|
|
SMILES |
C[C@H]1C[C@@H]2C3[C@@H]([C@H]([C@H]([C@]45[C@@H]3[C@H](O2)C(=C)[C@H]([C@H]4[C@@H](NC5=O)CC6=CC=CC=C6)C)O)O)C(=C1)C
|
|
InChI |
InChI=1S/C28H35NO4/c1-13-10-14(2)20-21-19(11-13)33-25-16(4)15(3)22-18(12-17-8-6-5-7-9-17)29-27(32)28(22,23(21)25)26(31)24(20)30/h5-10,13,15,18-26,30-31H,4,11-12H2,1-3H3,(H,29,32)/t13-,15-,18+,19-,20+,21?,22+,23+,24-,25-,26-,28-/m1/s1
|
|
InChIKey |
MLMRFXVBCDFIAD-LTMHNWRYSA-N
|
|
Synonyms |
Phomopchalasin B
|
|
CAS | NA | |
PubChem CID | 139591043 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 449.6 | ALogp: | 2.3 |
HBD: | 3 | HBA: | 4 |
Rotatable Bonds: | 2 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 78.8 | Aromatic Rings: | 6 |
Heavy Atoms: | 33 | QED Weighted: | 0.602 |
Caco-2 Permeability: | -5.239 | MDCK Permeability: | 0.00004380 |
Pgp-inhibitor: | 0.05 | Pgp-substrate: | 0.995 |
Human Intestinal Absorption (HIA): | 0.057 | 20% Bioavailability (F20%): | 0.05 |
30% Bioavailability (F30%): | 0.805 |
Blood-Brain-Barrier Penetration (BBB): | 0.113 | Plasma Protein Binding (PPB): | 86.93% |
Volume Distribution (VD): | 1.531 | Fu: | 7.03% |
CYP1A2-inhibitor: | 0.085 | CYP1A2-substrate: | 0.127 |
CYP2C19-inhibitor: | 0.096 | CYP2C19-substrate: | 0.57 |
CYP2C9-inhibitor: | 0.145 | CYP2C9-substrate: | 0.039 |
CYP2D6-inhibitor: | 0.015 | CYP2D6-substrate: | 0.179 |
CYP3A4-inhibitor: | 0.847 | CYP3A4-substrate: | 0.317 |
Clearance (CL): | 10.443 | Half-life (T1/2): | 0.188 |
hERG Blockers: | 0.423 | Human Hepatotoxicity (H-HT): | 0.769 |
Drug-inuced Liver Injury (DILI): | 0.772 | AMES Toxicity: | 0.035 |
Rat Oral Acute Toxicity: | 0.709 | Maximum Recommended Daily Dose: | 0.944 |
Skin Sensitization: | 0.13 | Carcinogencity: | 0.091 |
Eye Corrosion: | 0.003 | Eye Irritation: | 0.009 |
Respiratory Toxicity: | 0.974 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC003956 | 0.784 | D0SP3D | 0.223 | ||||
ENC005128 | 0.752 | D09NNH | 0.222 | ||||
ENC006060 | 0.696 | D0V3ZA | 0.222 | ||||
ENC004543 | 0.643 | D0R1BD | 0.220 | ||||
ENC003937 | 0.619 | D0IN7I | 0.217 | ||||
ENC005127 | 0.596 | D0M6VK | 0.217 | ||||
ENC005759 | 0.553 | D05ZJG | 0.217 | ||||
ENC003955 | 0.534 | D06CWH | 0.217 | ||||
ENC006133 | 0.521 | D08UMH | 0.216 | ||||
ENC005760 | 0.521 | D0I2VK | 0.216 |